Skip to main content

Table 4 Univariate Cox regression analysis

From: Role of protein tyrosine phosphatase receptor type M in epithelial ovarian cancer progression

Factors

β

SE

HR (95% CI)

P-value

PTPRM

-1.559

1.024

0.210(0.028,1.565)

0.128

Age

1.113

0.557

3.042(1.020,9.072)

0.046

CA125

1.517

0.436

4.559(1.94,10.716)

0.001

Clinical stages

2.567

0.626

13.022(3.821,44.379)

< .0001

Ascites

1.232

0.621

3.428(1.015,11.571)

0.047

Tumor diameter

-0.734

0.434

0.480(0.205,1.124)

0.091

Family history

0.561

0.484

1.752(0.679,4.521)

0.246

Age of menostasis

-0.228

0.461

0.796(0.323,1.964)

0.620

Age of menarche

0.475

0.427

1.607(0.697,3.709)

0.266

Comorbidities

0.288

0.441

1.334(0.563,3.164)

0.513

HE4

1.529

0.514

4.613(1.686,12.622)

0.003

CA19-9

-0.932

0.510

0.394(0.145,1.069)

0.068

Lymphatic metastasis

1.638

0.456

5.144(2.106,12.566)

< 0.001

  1. CA cancer antigen, CI confidence interval, HE4 human epididymis protein 4, HR hazard ratio, PTPRM protein tyrosine phosphatase receptor type M, SE standard error